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Abstract 
In connection with bilateral maxillary sinus augmentation, the acute effects of the 
nonsteroidal anti-inflammatory drug carprofen on facial expression and long-term effects on 
bone formation were evaluated in 18 male New Zealand White rabbits. A 10 x 10-mm bone 
window was drilled in the maxilla, the sinus membrane elevated and a titanium mini-implant 
inserted. One of two test materials was randomly inserted unilaterally and bovine bone chips 
(control) on the contralateral side in the created space. Rabbits were randomly allocated to 
receive buprenorphine plus carprofen (n=9) or buprenorphine plus saline (n=9) 
postoperatively. Buprenorphine was administered subcutaneously every 6 h for 3 d in a 
tapered dose (0.05-0.01 mg/kg) and carprofen (5 mg/kg) or saline administered 
subcutaneously 1 h before, and daily for 4 d postoperatively. To assess pain, clinical 
examination, body weight recording and scoring of facial expression from photos taken 
before, and 6-13 h after surgery was performed. Twelve weeks after surgery the rabbits were 
euthanized and sections of maxillary bones and sinuses were analysed with histomorphometry 
and by qualitative histology. 
Carprofen had no effect on mean facial expression scores, which increased from 0.0 to 3.6 
(carprofen) and 4.3 (saline), of a maximum of 8.0. Neither did carprofen have an effect on 
bone formation or implant incorporation, whereas the test materials had. 
In conclusion, treatment with 5 mg/kg carprofen once daily for 5 d did not reduce facial 
expression scores after maxillary sinus augmentation in buprenorphine treated rabbits and did 
not affect long term bone formation.   
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Introduction 
Orthopaedic procedures are considered among the most painful in experimental animal 
research and still only 50 % of orthopaedic studies in rabbits report the use of any analgesia 
(Coulter et al., 2011).  One reason for withholding analgesics may be that pain is difficult to 
assess in rabbits. Animals of prey are believed to mask pain-related behaviour to increase 
chances of survival, which may lead to the assumption that they do not experience pain 
(Johnston and Avian, 2005). Rabbits are for example known to remain motionless in the face 
of stress and pain. According to the European directive 63/2010, analgesic drugs must be 
provided to experimental animals in painful procedures (Directive 2010/63/EU, n.d.), and to 
effectively treat pain, it needs to be assessed correctly.  
Lately, evaluating facial expression has been shown to be useful for pain assessment in 
several species such as mice (Langford et al., 2010), rats (Sotocinal et al., 2011), horses  
(Dalla Costa et al., 2014; Gleerup et al., 2014), and rabbits (Keating et al., 2012). For 
assessment of pain in rabbits, facial expression scoring was validated for intense nociceptive 
stimulation (Keating et al., 2012). To our knowledge, there are no reports on the use of facial 
expression for the assessment of postoperative pain in rabbits.  
Another reason for withholding analgesics to rabbits in orthopaedic research is the fear of 
interaction with bone healing (Coulter et al., 2011). The effect of non-steroidal anti-
inflammatory drugs (NSAIDs) on bone healing has long been debated (Dodwell et al., 2010; 
Pountos et al., 2012) and the recommendation for their use in human beings varies between 
orthopaedic clinics. According to a recent meta analysis of bone healing in humans there is 
little evidence of an increased risk of non-union by the use of NSAIDs (Dodwell et al., 2010).  
Other studies report conflicting reults of NSAID on bone formation in humans (see 
Konstantinidis et al., 2013).  Some authors recommend not using NSAIDs in animals in 
which delayed bone healing can be suspected (Richardson, 2011), but there is insufficient 
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evidence to generally support the withholding of NSAIDs after orthopaedic surgery (Dimmen 
et al., 2009; Krischak et al., 2007). There is evidence from experimental studies in rabbits and 
rodents, that most NSAIDs have the potential to inhibit bone healing in the short-term 
perspective, depending on the timing, dose and duration (Endo et al., 2005; Gerstenfeld et al., 
2003; Simon et al., 2002). The inhibitory effects seem to be the greatest during the early 
phase of bone healing, but once administration is discontinued, compensatory mechanisms 
lead to normal healing (Gerstenfeld et al., 2007; Nyangoga et al., 2010).  
The rabbit is the most commonly used animal species in orthopaedic research (as reviewed by 
Pearce et al., 2007; Stübinger and Dard, 2013), with advantages of low cost, ease of handling 
and early skeletal maturity. Rabbits are suitable for screening of material implants in bone 
before further evaluation is undertaken in other large animals (International standards, ISO 
10993-2, 2006). Another area of research is the development of new materials for the 
replacement of bone. In humans with maxillary atrophy a widely used technique in 
connection with dental replacement is maxillary sinus augmentation (Stübinger and Dard, 
2013). With this technique, a new compartment is created between the floor of the maxillary 
sinus and the elevated sinus membrane, and new bone is allowed to be formed (Sohn et al., 
2010). This is needed for fixation of titan implants in the maxilla when bone is scarce. In 
rabbits, sinus augmentation can be modelled  for the evaluation of new materials that can 
replace autologous bone (Kim et al., 2012).  
The aim of the present study was to evaluate if the perioperative treatment with the NSAID 
carprofen 1) reduces facial expression scores in the immediate post 
-operative phase in buprenorphine treated rabbits and 2) interferes with long term formation 
of new bone in a model of maxillary sinus augmentation. The hypotheses were that carprofen 
would reduce facial expression scores and not interfere with long term bone formation. 
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For ethical reasons, all rabbits received buprenorphine for treatment of postoperative pain. In 
order to enclose a complete bone remodelling cycle, bone formation was evaluated after 12 
weeks (Bodde et al., 2007).  
 
Materials and methods:  
The experiment was approved by the local ethics committee for animal experiments in 
Uppsala  (C 70/13). 
Experimental design 
The rabbits were randomized to receive either buprenorphine and carprofen (Group 
Bup+Carp, n=9) or buprenorphine and saline (Group Bup+Sal, n=9). Carprofen, at a dose of 5 
mg/kg (Norocarp vet, 50 mg/ml, N-Vet, Uppsala, Sweden), or the equivalent volume of 
saline, was administered subcutaneously (s.c.) 40 min before surgery and daily for 4 d after 
surgery. All rabbits received buprenorphine (Temgesic
®
, 0.3 mg/ml, RB Pharmaceuticals, 
Slough, Berkshire, UK) after completion of surgery at a dose of 0.03 mg/kg intravenously 
(i.v) and 0.02 mg/kg s.c and repeated s.c. at 0.05 mg/kg after 6 h, at 0.03 mg/kg between 12 
and 24 h, at 0.02 mg/kg between 36 and 48 h, and at 0.01 mg/kg between 60 and 72 h 
postoperatively. The first dose of buprenorphine was partly administered i.v. to antagonise the 
effects of the anaestesic agent sufentanil, and thereby increase the rate of recovery. 
The rabbits were randomized to receive one of two bone augmentation materials (A and B) 
within each analgesia group for their potential as substitute for autologous bone and their 
bone induction properties. One material was a new granular composition of calcium 
phosphates (OssDsign, Uppsala, Sweden;  Engstrand et al., 2014) and the other material a 
bisphosphonate linked hyaluronic acid hydrogel (BHA; Hulsart-Billström et al., 2013). The 
materials (n=9+9) were placed in the maxillary sinus on a random side, and on the 
contralateral side standard bovine-derived hydroxyapatite chips (Bio-Oss®, Geistlich Pharma 
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AG, Wolhusen, Switzerland; Mordenfeld et al., 2010) were placed as control (n=18). See 
table 1.  
Animals and housing 
Eighteen male New Zealand White (NZW) rabbits from a specific-pathogen-free colony 
(Lidköpings Kaninfarm, Lidköping, Sweden) were used. The breeding colony was free from 
known rabbit pathogens, as according to health monitoring reports (Mähler Convenor et al., 
2014). At the time of surgery, the rabbits were 36 ± 4 weeks old and weighed 3.7 ± 0.2 kg 
(mean ± SD). The rabbits were housed individually in cages with a floor area of 0.42 m
2
, and 
were equipped with a shelf and a covered area. Standard pelleted rabbit diet (Lactamin K3, 
Lantmännen, Stockholm, Sweden) and autoclaved hay was fed to the rabbits, which had 
access to autoclaved straw for bedding and water in bottles. The light – dark cycle was 12:12 
h with lights on at 07:00. Room temperature was 18 ± 3° C and humidity 55 + 10 %.  
The animals were acclimatized for two weeks and accustomed to handling. On the day before 
surgery, the rabbits were clinically examined (gereral appearance and behaviour, heart and 
lung auscultation, body orifices inspected) and 2 ml blood was collected from the ear artery 
after topical treatment with a local anaesthetic cream (EMLA
®
, AstraZeneca, Södertälje, 
Sweden). The acute phase protein serum amyloid A (SAA) was analysed by enzyme-linked 
immunosorbent assay (Tridelta Development Ltd, Maynooth, Ireland) as a marker of 
inflammation. The rabbits were not fasted at any time point. 
Preparations for surgery 
On the day of surgery, the rabbits were administered 2 mg/kg of medetomidine (Domitor
®
 
Orion Pharma Animal Health, Sollentuna, Sweden) s.c. and local anaesthetic cream (EMLA
®
) 
on the skin over the ear veins and arteries. After 30 min, the rabbits were moved to the 
surgery preparation room and administered 5 mg/kg of ceftiofur (Exenel
®
, Orion Pharma AB, 
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Animal Health, Sollentuna, Sweden) s.c. Catheters (Venflon™, BD AB Stockholm, Sweden) 
were placed in one ear artery (20 G) and vein (22 G). Anaesthesia was induced by continuous 
infusion of 4.5 µg/kg/h sufentanil (Sufenta
®
, Jansen-Cilag, Sollentuna, Sweden) and 0.9 
mg/kg/h midazolam (Midazolam Actavis, Actavis AB, Stockholm, Sweden) and maintained 
with continuous intravenous infusion of sufentanil and midazolam according to Hedenqvist et 
al. (2013). After induction, a larynx mask (V-gel, large, Docsinnovent, London, UK) was 
introduced into the oral cavity, and connected to the anaesthesia machine (Anmedic Q-Circle 
System; Anmedic AB, Stockholm, Sweden) via a paediatric breathing system (Intersurgical 
Ltd, Wokingham, UK). Oxygen was administered at a rate of 1.5 L/min. To maintain an end 
tidal CO2 of 5–7 kPa, the lungs were ventilated with a respiratory frequency of 10–20/min, a 
maximum peak inspiratory pressure of 20 cm H2O and an inspiration: expiration ratio of 1:3 
with a ventilator (Anmedic vent JB1; Anmedic AB, Stockholm, Sweden). After skin 
preparation of the incision areas, 4.5 mg (0.9 ml) of prilocain (Citanest
®
, 5 mg/ml, 
AstraZeneca, Sweden) was administered s.c. per side. 
Surgical procedure  
Surgery was performed by a skilled, experienced maxillofacial surgeon (ATh). A bilateral 
maxillary sinus augmentation was performed by incising the skin over the maxilla a few mm 
above the ventral border of the incisive bone and the maxilla. The muscles and periosteum 
were exposed and elevated. A bone window (10 x 10 mm) was created by piezo-electric 
surgery (Mectron s.p.a., Carasco, Italy), the sinus membrane elevated and a miniature dental 
titanium implant (2.2 x 6 mm, custom made, Enge Mikroteknik, Vittsjö, Sweden) inserted in 
the edentulous alveolar ridge. The newly formed sinus space in the bone was augmented with 
test or control material. A 25 x 25 mm collagen membrane (Geistlich Bio-Gide
®
, Geistlich 
Pharma AG, Wohlhausen, Switzerland) was applied over the grafted site to keep the material 
in place. The soft tissue was relocated and sutured with Monocryl sutures 5-0 (Ethicon, 
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Johnsons & Johnson AB, Sollentuna, Sweden) in two layers (muscles and skin). The surgery 
lasted for 60-90 min.  
Monitoring and postoperative care 
During anaesthesia end-tidal CO2, heart rate, respiratory rate, rectal temperature and 
hemoglobin oxygen saturation (SpO2, probe on tail) were monitored continuously (CS/ 3; 
Datex-Engstrom, Datex Ohmeda, Bromma, Sweden).  After completion of surgery, the 
anaesthesia infusion was discontinued and atipamezole, 1 mg/kg s.c., (Antisedan
®
 vet., Orion 
Pharma Animal Health, Sollentuna, Sweden) and flumazenil, 0.1 mg i.v. (Flumazenil Actavis, 
Stockholm, Sweden), were administered. Postoperatively, body temperature, respiration rate, 
heart rate and SpO2 were recorded every 15 minutes for 3 h, after which rabbits were returned 
to their home cage. Ceftiofur (5 mg/kg) was administered s.c.once daily for 4 d 
postoperatively. Rabbits were weighed daily for one week after surgery and thereafter weekly.  
Pain assessment 
For facial expression scoring, photographs (Panasonic Lumix DMC-T27, Osaka, Japan) were 
taken of the rabbit’s face from the front and from the side in the home cage, before surgery 
and at 6, 7, 12 and 13 h postoperatively. The 6 and 12 h photographs were taken immediately 
before administration of buprenorphine. A total of 180 pictures were taken, randomly 
numbered, and scored by five observers which were blinded to treatment and time point. The 
observers were two of the authors (ATr, MJW), two veterinary students (GH, MK) and one 
non-veterinary student (LJW), which were instructed by reading descriptions and viewing 
examples pictures from the publication on the Rabbit Grimace Scale by Keating et al. (2012). 
The scale comprises 5 so called Facial Action Units (FAUs); orbital tightening, ear poition, 
cheek flattening, pointed nose and whisker change, each evaluated on a scale from 0-2 (0=no 
change, 1= moderate change, 2=obvious change from normal). Additionally, pictures were 
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scored subjectively for the presence of pain, ranging from 0 (no pain) to 3 (severe pain).  
Postmortem sampling 
Three months after surgery, the rabbits were euthanized i.v. with pentobarbital (Allfatal
®
 vet., 
Omnidea AB, Stockholm, Sweden). The heads were immediately removed and examined by 
cone beam computer tomography (3D Accuitomo 170 J.Morita, Irvine, CA, USA), to guide 
the exact excision of the maxillary bone blocks (Fig 2). The parts of the maxilla containing 
the implants were then removed using a band saw (KT-460, Klaukkala, Finland) .  
Sample processing 
In brief, the bone tissue samples were immersed in 10 % neutral-buffered formalin fixative 
followed by rinsing in tap water. The samples were dehydrated in increasing concentrations 
(70% - 100%) of ethanol, preinfiltrated in diluted resins prior to infiltration in pure resin and 
finally embedded in pure resin and allowed to polymerize under UV light. Undecalcified cut 
and ground sections were prepared according to the method described by (Donath and 
Breuner, 1982) using the ExaktR equipment  (Exakt Apparatebau, Norderstedt, Germany). 
The cured samples were divided in the water-cooled band-saw and the surface of each bloc 
was ground parallel prior to be glued onto a supporting plexi-glass. An initial thick section 
was prepared which then was ground (using SiC wet grinding papers starting with 800 grit up 
to 1200 grit papers) in a water-cooled grinding equipment. No final polishing was used. The 
sections were prepared to have a final thickness of about 15µm and finally the sections were 
routinely stained in a mixture of toluidine blue and pyronin G (Johansson and Morberg, 1995) 
Histology evaluation 
Qualitative histology was examined by light microscopy (Nikon eclipse E600) by two 
veterinary pathologists (CL, SE) who were blinded to treatments (material A/B/BHA and 
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carprofen/saline). After scoring individually, the two pathologists agreed on a consensus 
scoring. One section per animal from each side (material A/B/BHA) was examined for degree 
of implant incorporation in bone (good, satisfactory or poor) and test material association with 
bone (yes or no) (Table 2). The degree of implant incorporation was evaluated according to 
the following criteria: amount of bone surrounding the implant, amount of grooves containing 
bone and amount of direct contact between bone and implant. If all three parameters were 
fulfilled; i.e. the implant was surrounded by moderate or abundant bone, and moderately-
extensively incorporated in regard to numbers of grooves filled with bone and presence of 
direct bone-implant contact, the incorporation was scored as good and if only one or two of 
the criteria were adequate the incorporation was satisfactory, otherwise poor.  When the test 
material showed a moderate or major association with bone it was graded yes (Table 2). No 
association with bone or a minor focal area of bone adjacent to the test material was 
considered no.  
The sections were also designed as adequate when: all components could be assessed or 
where artefacts were present but bone formation still could be assessed. 
For quantitative analysis histomorphometry was performed (Nikon E600 microscope, Nikon 
DXM 1200 digital camera, software: NIS-elements Basic Research, Nikon, Tokyo, Japan) 
The new bone within the grafted material and the implant incorporation were measured by 
one of the authors (ATr) who was blinded to treatment with carprofen but not to the materials. 
The new bone was differentiated from the existing "old" bone in the specimens by slightly 
lighter coloration in staining. The old bone had a more matured apparence (sharper defined 
lamellae) and contained less osteocytes. Because of the fact that the sinus membrane was 
elevated by the micro-implant, old and mature bone could only be expected to be found in the 
cervical part of the implant where the mechanical retention of the implant primarily took 
place, meaning bone at the first two-three implant threads. New bone attached to the bovine 
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bone particles could also easily be detected in a similar way as seen in Fig 3. For evaluation, 
two regions of interest (ROI) were defined: 1) A free size region of the observed test or 
control material area in 1 x magnification (“free ROI”) and 2) A defined rectangular sized 
area of interest (3.5 x 2.5 mm), with augmented material in close approximation to the 
implant apex, in 4 x magnification (”rectangular ROI”). The implant incorporation was 
evaluated by measuring the bone formation in an area between six implant threads located 
marginally and on both sides of the implant (“implant ROI”). The amount of new bone was 
marked, measured and expressed as a percentage of the total ROI area. For example areas see 
Fig 3A-C. 
Statistical analyses 
Data were analysed for normality and homogeneity of variance. Body weight, subjective pain 
scores and facial expression scores were compared with two-way repeated measures 
ANOVA, with group and time point as factors. For comparison between time points, a 
posthoc Bonferroni t-test was performed (all pair wise multiple comparison).  
For the facial expression and subjective pain evaluation respectively, scores were calculated 
for each animal, time point and observer, by adding the scores from two pictures. From the 
scores from all observers means and standard deviations were calculated for the ANOVA.   
SAA levels were compared with repeated measures ANOVA on ranks within each group and 
with rank sum test between groups at all three time points. The area under the curve (AUC) 
for facial expression scores over time were compared with t-test between analgesia groups. 
Qualitative histology scoring was evaluated using Fisher’s exact test on the distribution of 
scores in Group Bup+Carp and Group Bup+Sal in the sinus treated with BHA (control). 
Morphometric results of bone formation in the sinus treated with BHA were compared by 
independent t-tests between groups with and without carprofen. The effect of carprofen on 
bone formation on the side with test material was evaluated by a two-way ANOVA, with 
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material A/B and carprofen/saline as factors. The new bone amount measured in the ROIs 
were compared between materials A and B by t-test, and between the materials and the 
controls by paired t-test. A p-value <0.05 was considered significant. 
 
Results  
Clinical parameters 
Anaesthesia, surgery and recovery from the procedure were uneventful. Mean duration of 
anaesthesia was 118 ± 14 min and time to recovery of the righting reflex after discontinuation 
of anaesthesia was 15 ± 6 min. Mean doses of sufentanil and midazolam during surgery were 
3.8 µg/kg/h and 0.76 mg/kg/h, respectively. 
Preoperative SAA values were below detection level (<4.7 ng/ml) in all but two rabbits (6.4 
and 7.6 ng/ml). Three days postoperatively, the median levels were increased to 37 ng/ml 
(range 12-182 ng/ml) in Group Bup+Carp, and 51 ng/ml (range 23-199 ng/ml) in Group 
Bup+Sal, with no difference between groups. By d 21 the levels were similar to preoperative 
levels (Fig 4). 
All rabbits resumed eating within 12 h without handfeeding. One of the first rabbits that 
underwent surgery was reluctant to drink from the water bottle, and therefore water bowls 
were placed in all cages. Mean body weight loss was 0.28 ± 0.13 kg (8%) in Group Bup+Carp 
and 0.24 ± 0.26 kg (7%) in Group Bup+Sal and had returned to baseline on postoperative day 
21. Body weights did not differ between groups on any day (Fig 5).  
 
Facial expression and subjective pain scores.  
Of the FAUs, nose pointing or cheek flattening were not detected at any time point in the 
present study and whisker position was found difficult to assess, thus these FAUs were 
excluded from the statistical evaluation. Orbital tightening and ear position (eye and ear 
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scores) were easy to assess and thus, the maximum score for each image was 4 and at each 
time point 8. For examples of FAU scores see Fig 1. The maximum subjective score for each 
animal at each time point was 6. 
Eye and ear scores as well as subjective pain scores were increased in both groups 6 and 7 h 
after surgery, and in Group Bup+Carp the scores were still increased after 12 and 13 h. Fig 6 
shows eye and ear scores. The AUC of the eye and ear score over time did not differ between 
groups (31 ± 8 and 31 ± 15). Mean subjective scores increased from 0.0 to 2.6 ± 0.6 in Group 
Bup+Sal and to 2.3 ± 0.2 in Group Bup+Carp.   
There was no difference between groups at any time point, or between scores before and after 
buprenorphine administration in either group. The same results were found when ear position 
and orbital tightening were evaluated individually (data not shown).  
 
Bone formation  
There was neither an effect of carprofen on new bone formation on the side treated with the 
control material BHA (Table 2 and Fig 7A), nor on the side treated with test material A/B 
(Fig 7B).  There was however a difference for all three ROIs in the amount of new bone 
formation between material A and B, but not between the materials and their controls (Fig 
7C). 
Discussion  
The use of NSAID in orthopaedic research is controversial. The current study was conducted 
to evaluate the potential of carprofen to provide additional postoperative analgesia in 
buprenorphine treated rabbits as well as its effect on bone healing in a sinus lift model. Facial 
expression scoring (Keating et al., 2012) revealed that the FAU scores for orbital tightening 
and ear position were increased, suggesting that they can be useful for assessing postoperative 
pain in rabbits. There was however no difference beween rabbits that received carprofen and 
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those that did not, suggesting that either the scoring method was not very sensitive, that the 
carprofen could not add any additional analgesia, or that the dose was too low. Further there 
was no difference between scores before and 1h after buprenorphine administration, 
indicating that either the dose of buprenorphine was inadequate, the time point for evaluation 
too soon, or that there was residual analgesia from the previous administration of 
buprenorphine. Buprenorphine is slowly concentrated in deep tissue department (Andaluz et 
al., 2009) and the peak analgesic effect in our rabbits may not have been reached after 1 h. 
Analgesiometric tests in NZW rabbits have shown that the peak effect after s.c. injection of 
0.03 mg/kg occurs after 3-4 h (Flecknell and Liles, 1990). The duration of action is known to 
be long, due to the high affinity to the opioid µ-receptor and slow dissociation (Roughan and 
Flecknell, 2002). In rabbits, re-administration is recommended after 8-12 h (Carpenter,  
2005), yet in the current study, administration was repeated every 6 h. A control group 
without analgesic treatment would be helpful in determining the efficacy of treatment, but is 
considered unethical. Another way would be to examine if there is a dose-effect realationship. 
However, buprenorphine has been shown to have an analgesic effect in rabbits in doses lower 
than that used in the present study (Flecknell and Liles, 1990; Wootton et al., 1988) and 
likewise carprofen after ovariohysterectomy in rabbits in the same dose as in the present study 
(Flecknell et al., 2004). The dose of carprofen in the present study was higher than the 
recommended dose interval: 2-4 mg/kg (Carpenter, 2005; Ramsey, 2008; Varga, 2014 ).  
With a group of rabbits receiving only carprofen, a comparison of the efficacy between 
carprofen and buprenorphine would be possible. At 12 and 13 hours after surgery, the ear and 
eye scores were still increased only in Group Bup+Carp. This could be explained by an opioid 
induced hypersensitivity, which however is typically regarded as a hyperalgesic state and not 
necessarily an increase in spontaneous pain (Wala and Holtman, 2011). 
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Subjective scoring was as effective as facial expression scoring in the current study, which 
may be due to the fact that they were performed simultaneously and thus liable to bias by the 
observer. Another possibility could be that the observers were experienced in observing 
animals in painful conditions. Scoring postoperative pain by evaluating facial expression has 
been described in other species. In mice, facial expression scores were reduced by meloxicam 
treatment after vasectomy (Leach et al., 2012). In rabbits on the other hand, it has been 
suggested that it may be more effective not looking at the face for postoperative pain 
assessment, although that is what people tend to do (Leach et al., 2011). In a study of pain 
related behaviour in rabbits it was further suggested that the increased duration of orbital 
tightening after abdominal surgery was due to sedation by residual isoflurane anaesthesia, and 
it was therefore disregarded as a sign of pain (Farnworth et al., 2011). In the present study, the 
rabbits were anesthetised by intravenous infusion, and antidotes were administered for rapid 
recovery. From a pilot study it was further estimated that anaesthesia was completely worn 
off after 6 h, the first time point for facial expression scoring. The benefit of using facial 
expression for assessment seems to be that it is not affected by opioid treatment per se, which 
has been shown in naïve mice (Langford et al., 2010) and rabbits (Keating et al., 2012). 
Moreover, pain facial expression seems to be related to the affectionate part of pain, which is 
indicated in studies in mice by the destruction of the cingulate cortex (CC), indicated to be the 
site of the affective part of pain. After destruction of the CC in mice with inflammatory 
conditions, facial expression scores are reduced whereas behaviours such as writhing are 
unaffected (Langford et al., 2010).   
A previously developed behaviour based pain scoring system for assessing postoperative pain 
in rabbits, which does not take FAUs in account, is much more time consuming and therefore 
of little practical use (Leach et al., 2009). Moreover it uses behaviours that are specific to 
abdominal surgery, restricting its use even further. Facial expression scoring on the other 
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hand, can be performed quickly and easily, and may be useful for pain assessment after 
different types of surgical procedures.  Though simple to perfom, facial expression scoring 
also needs to be sensitive enough to distinguish different degrees of pain to be of value. 
In the present study, scoring was performed by assessing only two FAUs; orbital tightening 
and ear position. These are easily and rapidly evaluated even by inexperienced persons.  
The other FAUs described by Keating et al. (2012); flattening of the cheeks, pointy nose and a 
change in whisker position, were not distinguishable in the present study. This could be due to 
inhibition of grimacing by the localization of the pain or because these FAUs are not 
expressed with postoperative pain which is of another character and connected with activation 
of c-fibers unlike acute physiological pain that is elicited by activation in A-delta-fibers 
(National Research Council, 2009). 
The intensity of pain was not expected to be severe, since sinus lift is a  rather small surgical 
procedure which only causes mild pain in humans (Block and Kent, 1989; Pal et al., 2012). 
With the exception of tonsillectomy, ear-nose-throat surgery, comparable to the surgery in the 
present study, is known to cause relatively little pain in humans (Gerbershagen et al., 2013). 
Moreover, the surgeries in the present study were performed by a skilled surgeon (ATh), 
causing a minimum of trauma. The perioperative analgesic treatment consisted of local 
anaesthesia infiltration, opioid-based anaesthesia and immediate postoperative buprenorphine 
administration which may have prevented the development of excessive hyperalgesia and 
facilitated the control of postoperative pain. The highest mean score reached was 4.0 out of a 
maximum of 8.0, which could be interpreted as moderate level of pain. Considering the 
multimodal analgesic approach, the scores are relatively high and the  possibiltiy that the pain 
was undermanaged cannot be excluded.  
The levels of the acute phase protein SAA, which is a valuable inflammatory marker, did not 
differ between groups. This may be an indication that the dose of carprofen was suboptimal. 
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In a study of piglets undergoing castration, SAA levels were lower in piglets that received 
meloxicam in comparison to controls (Hansson et al., 2011). The levels in the current study 
were similar to those in a study on NZW rabbits undergoing knee cartilage surgery (Aulin et 
al., 2013).  
The evaluation of carprofen treatment on bone formation showed that there was no difference 
compared to controls after three months. All installed micro-implants integrated well into the 
bone. The incorporation of implants into bone as well as the amount of new bone created in 
proximity to the materials were found to be equal regardless of treatment with carprofen. The 
mechanism of inhibition on bone formation by NSAIDs has not been fully explained, but the 
predominant theory is that the reduced production of prostaglandins causes interference with 
cell signalling during the inflammatory phase of bone healing (as reviewed by Barry, 2010). 
Studies in knock-out mice have shown that cyclooxygenase (COX)-2 is essential for 
endochondral and intramembranous bone formation (Zhang et al., 2002). Carprofen is 
believed to be a weak peripheral inhibitor of COX iso-enzymes (McKellar et al., 1994) and 
other mechanisms by which carprofen can act anti-inflammatory have been identified in vitro, 
such as modification of interleukin (IL)-1 and IL-6 release and inhibition of reactive oxygen 
species (Armstrong and Lees, 2002).  
In summary, obital tightening and ear position scores were increased after maxillary sinus 
surgery in rabbits. Perioperative analgesic treatment with 5 mg/kg carprofen for 5 d, in 
addition to buprenorphine treatment, did not reduce the scores and did not interfere with long 
term bone formation in this sinus lift model.    
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 Table 1: Exprerimental design 
Eighteen male NZW rabbits were randomised to analgesia Group Bup+Carp or Group 
Bup+Sal. Within each analgesia treatment group, the rabbits were randomised to sinus 
augmentation subgroups with either test material A (granular composition of calcium 
phosphates) or B (hyaluronic acid hydrogel ) on one side of the skull. All rabbits were 
augmented with standard bovine-derived hydroxyapatite chips (BHA) as control on the contra 
lateral side.  
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Table 2: Subjective evaluation of bone formation 
Qualitative evaluation of the maxillary sinus augmented with standard bovine-derived 
hydroxyapatite chips for control (BHA). Fisher's exact test was performed between 
analgesia Group Bup+Carp and Group Bup+Sal. For the comparison, the sections that were 
scored good or intermediate for incorporation of implant in bone were pooled.  
 
Fig 1. Examples of pictures with different scores for facial action units ear position (0-2), and 
orbital tightening (0-2).  A: Photo taken before maxillary sinus surgery and augmentation (ear 
position 0, orbital tightening 0). B-D: Photos taken after surgery (note the location of the 
incision). B: ear position 2, orbital tightening 2. C: ear 1, eye 2. D: ear 2, eye 0.   
 
Fig 2. Scans of a rabbit head with cone beam computer tomography showing the location of 
the titanium mini-implants (black arrow) and the augmentation material (white arrow) in the 
maxillary sinus. A: Lateral exposure. B: ventral exposure. 
 
Fig 3. Photographs of three region of interests that were defined for the objective evaluation 
of new bone formation (red colour) after sinus lift and augmentation in NZW rabbits. The 
figures all show the control side with bovine bone chips (purple colour)  in the area of the 
titanium implant (black colour). Old bone surrounds the upper part of the implant. The size of 
the implant is 2.2 x 6 mm. Note how new bone has been created around the bovine bone chips 
(B). A: a free region of interest placed in the area of material deposit. B: a defined rectangular 
region of interest (3.5 x 2.5 mm) in 4 x enlargement placed in the area of material deposit.  C. 
Implant region of interest in the area of the 6 most marginal located threads on both sides of 
the implant. 
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Fig 4. Serum levels of amyloid A in NZW rabbits before and 3, 21 and 94 d  after maxillary 
sinus lift and augmentation in Group Buprenorhine + Carprofen and Group Buprenorphine + 
Saline. Whiskers represent minimum and maximum. Repeated measures ANOVA on ranks,  
*p<0.05. 
 
Fig 5. Mean (SD) body weight in NZW rabbits before and after maxillary sinus surgery and 
augmentation. A two-way repeated measures ANOVA (posthoc Bonferroni t-test) showed 
that there were no differences between Group Buprenorhine + Carprofen and Group 
Buprenorphine + Saline at any time point. Rabbits in both groups lost weight during the first 
week:  *p<0.05 in comparison with body weight before surgery.  
 
Fig 6. Mean (SD) facial expression scores based on ear position (0-2) and orbital tightening 
(0-2) in NZW Rabbits before and after maxillary sinus lift and augmentation. Rabbits 
received either Group Buprenorhine + Carprofen and Group Buprenorphine + Saline. 
Buprenorphine was administered immediately after the 6 h and 7 h time points. * P<0.05, † 
P<0.05 for comparison over time within each group. Two-way repeated measures ANOVA, 
posthoc Bonferroni t-test.  
 
Fig 7. Mean amount of new bone measured with morphometry and expressed as a percentage 
of the total region of interest in NZW Rabbits after maxillary sinus lift and augmentation. 
Comparison between groups with Mann-Whitney Rank Sum Test (*p<0.05, *** p<0.001).  
7A: No difference between Group Buprenorphine + Carprofen and Group Buprenorphine + 
Saline in bone amount on the control side, which was augmented with bovine bone chips 
(BHA).  
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7B: No difference between between Group Buprenorphine + Carprofen and Group 
Buprenorphine + Saline in bone amount on the side that was augmented with material A or B. 
7C: Difference in bone amount between material A and  B in all three measurements.  T-test, 
(*p<0.05, *** p<0.001). 
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Fig. 1B 
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Fig. 1C 
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Fig. 1D 
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Fig. 2A 
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Fig. 2B 
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Fig. 3A 
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Fig. 3B 
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Fig. 3C 
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Fig. 4 
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Fig. 5 
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Fig. 6 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
40 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
41 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
42 
 
 
Fig. 7c 
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Table 1 
 
 
 
 
 
 
 
 
 
 
 
  
 Analgesic treatment groups 
 
 Buprenorphine + carprofen (n=9) 
 
Buprenorphine + NaCl (n=9) 
Sinus 
augmentation 
subgroups 
Test material A 
(n=5) 
Test material B 
(n=4) 
Test material A 
(n=4) 
Test material B 
(n=5) 
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Table 2 
Quality 
parameter 
Incorporation of implant in 
bone 
Test material associated with 
bone 
Group Good Intermediate Poor Yes No 
Bup + NSAID 
(n=9) 
6 3 0 9 0 
Bup + NaCl 
(n=8)* 
3 4 1 7 1 
p-value 
(Fisher’s exact 
test) 
0.47 0.47 
* one section was excluded due to artefacts 
